Evidence map›Paper›PMID 39584907›Full record

ArticleBiotech (Basel (Switzerland))2024

Leveraging Walnut Somatic Embryos as a Biomanufacturing Platform for Recombinant Proteins and Metabolites.

Paulo A Zaini, Katherine R Haddad, Noah G Feinberg, Yakir Ophir, Somen Nandi, Karen A McDonald, Abhaya M Dandekar

Abstract read
In one paragraph

Article in Biotech (Basel (Switzerland)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulo A ZainiDepartment of Plant Sciences, University of California, Davis, CA 95616, USA.ORCID 0000-0001-6495-7942
Katherine R HaddadDepartment of Chemical Engineering, University of California, Davis, CA 95616, USA.
Noah G FeinbergDepartment of Plant Sciences, University of California, Davis, CA 95616, USA.
Yakir OphirDepartment of Chemical Engineering, University of California, Davis, CA 95616, USA.ORCID 0009-0000-7467-5914
Somen NandiDepartment of Chemical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0001-5240-198X
Karen A McDonaldDepartment of Chemical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0002-5145-9968
Abhaya M DandekarDepartment of Plant Sciences, University of California, Davis, CA 95616, USA.ORCID 0000-0001-7925-4086

Funding

U.S. Department of Commerce (DOC), National Institute of Standards and Technology (NIST) through BioMADE to UC Davis 70NANB22H017
6 · The paper itself

Abstract

Biomanufacturing enables novel sources of compounds with constant demand, such as food coloring and preservatives, as well as new compounds with peak demand, such as diagnostics and vaccines. The COVID-19 pandemic has highlighted the need for alternative sources of research materials, thrusting research on diversification of biomanufacturing platforms. Here, we show initial results exploring the walnut somatic embryogenic system expressing the recombinant receptor binding domain (RBD) and ectodomain of the spike protein (Spike) from the SARS-CoV-2 virus. Stably transformed walnut embryo lines were selected and propagated in vitro. Both recombinant proteins were detected at 3-14 µg/g dry weight of tissue culture material. Although higher yields of recombinant protein have been obtained using more conventional biomanufacturing platforms, we also report on the production of the red pigment betanin in somatic embryos, reaching yields of 650 mg/g, even higher than red beet

Indexed as

biomanufacturingdiagnosticnatural pigmenttissue culturevaccinewalnut somatic embryos

Identifiers

PMID39584907
PMCPMC11586998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.